ABVC BIOPHARMA INC's ticker is ABVC and the CUSIP is 00091F106. A total of 10 filers reported holding ABVC BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | – | 11,371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ROYAL BANK OF CANADA | 239 | $0 | 0.00% |
| VANGUARD GROUP INC | 375,142 | $330,000 | 0.00% |
| JANE STREET GROUP, LLC | 11,371 | $10,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 116 | $0 | 0.00% |
| NORTHERN TRUST CORP | 18,421 | $16,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 139,653 | $122,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11,011 | $10,000 | 0.00% |
| BlackRock Inc. | 38,665 | $34,000 | 0.00% |
| Citadel Advisors | 12,612 | $11,000 | 0.00% |